Abstract
Diaryl sulfides also known as diphenyl sulfides, phenylthiobenzylamines, and biphenylthiols are a class of compounds with phenylthiophenyl scaffold that have been validated as biomarkers to label the brain serotonin transporter (SERT), in vivo. The development of those synthetic and non-natural compounds started more than a decade ago when the observation that 5-chloro-((2-((dimethylamino)methyl)phenyl)thio)benzene-methanol hydrochloride also called 403U76 inhibited the serotonin and norepinephrine uptake into rat brain synaptosomes, led to the preparation of few derivatives based on 403U76 chemical structure. The new class of compounds, called the diaryl sulfide family, was investigated as biomarkers for the brain SERT. The promising data demonstrated by the carbon-11 labeled diaryl sulfides led to the translation of few of them into humans and the further evaluation of the phenylthiophenyl core structure by developing some fluorinated derivatives. This review will mainly focus on the fluorinated diaryl sulfides as fluorine-containing tracers validated to image the human brain SERT using positron emission tomography.
Keywords: Biphenylthiols, Diaryl Sulfides, Diphenyl Sulfides, Fluorine-18, Phenylthiobenzylamines, Serotonin Transporter.
Current Topics in Medicinal Chemistry
Title:Fluorinated Diaryl Sulfides
Volume: 13 Issue: 8
Author(s): Nashwa Jarkas
Affiliation:
Keywords: Biphenylthiols, Diaryl Sulfides, Diphenyl Sulfides, Fluorine-18, Phenylthiobenzylamines, Serotonin Transporter.
Abstract: Diaryl sulfides also known as diphenyl sulfides, phenylthiobenzylamines, and biphenylthiols are a class of compounds with phenylthiophenyl scaffold that have been validated as biomarkers to label the brain serotonin transporter (SERT), in vivo. The development of those synthetic and non-natural compounds started more than a decade ago when the observation that 5-chloro-((2-((dimethylamino)methyl)phenyl)thio)benzene-methanol hydrochloride also called 403U76 inhibited the serotonin and norepinephrine uptake into rat brain synaptosomes, led to the preparation of few derivatives based on 403U76 chemical structure. The new class of compounds, called the diaryl sulfide family, was investigated as biomarkers for the brain SERT. The promising data demonstrated by the carbon-11 labeled diaryl sulfides led to the translation of few of them into humans and the further evaluation of the phenylthiophenyl core structure by developing some fluorinated derivatives. This review will mainly focus on the fluorinated diaryl sulfides as fluorine-containing tracers validated to image the human brain SERT using positron emission tomography.
Export Options
About this article
Cite this article as:
Jarkas Nashwa, Fluorinated Diaryl Sulfides, Current Topics in Medicinal Chemistry 2013; 13 (8) . https://dx.doi.org/10.2174/1568026611313080006
DOI https://dx.doi.org/10.2174/1568026611313080006 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Search for γ-Secretase and Development of Inhibitors
Current Medicinal Chemistry The Association of Very High Hair Manganese Accumulation and High Oxidative Stress in Mongolian People
Current Aging Science Impact of Telaprevir in HCV Patients with Cirrhosis and RVR: Real-Life Data from Boceprevir or Telaprevir based “Triple Therapy” Experience in Southern Italy
Reviews on Recent Clinical Trials Oncogenic Signalling Networks and Polypharmacology as Paradigms to Cope with Cancer Heterogeneity
Current Proteomics Editorial [Hot Topic: Youth at Risk for Psychosis (Guest Editors: Steven Adelsheim and David Graeber)]
Adolescent Psychiatry GABAergic Functions and Depression: From Classical Therapies to Herbal Medicine
Current Drug Targets - CNS & Neurological Disorders Impact of Antiretroviral Therapy on the Relapse of Cryptococcosis and Survival of HIV-Infected Patients with Cryptococcal Infection
Current HIV Research Can Genetics Help in Treatment of Smoking Addiction?
Current Pharmacogenomics and Personalized Medicine Interleukin-18, From Neuroinflammation to Alzheimers Disease
Current Pharmaceutical Design Females Live Longer than Males: Role of Oxidative Stress
Current Pharmaceutical Design Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
Current Pharmaceutical Design New Indications for Corticosteroids in Intensive Care Units
Current Drug Targets Editorial [Hot Topic: Recent Discoveries in the Search for Novel Antidepressants and Anxiolytics (Executive Editors: D. Bleakman and D. Gehlert)]
Current Pharmaceutical Design Cardiac Sarcolemmal Ion Channels and Transporters as Possible Targets for Antiarrhythmic and Positive Inotropic Drugs: Strategies of the Past-Perspectives of the Future
Current Pharmaceutical Design subject Index To Volume 2
Current Topics in Medicinal Chemistry An Integrated and Disease-Oriented Growth Factor-Regulated Signal Transduction Network
Current Molecular Medicine Recent Advances of Butelase 1 in Peptide/Protein Ligations
Current Organic Chemistry Regulation of Expression and Function of IDO in Human Dendritic Cells
Current Medicinal Chemistry The <i>locus</i> of Action of CGRPergic Monoclonal Antibodies Against Migraine: Peripheral Over Central Mechanisms
CNS & Neurological Disorders - Drug Targets Influence of Different Substituents on Anion Binding Ability in Aromatic Hydroxyl Group Derivatives: Experiment and Theory
Current Analytical Chemistry